18 Jul by Vitaliy Dadalyan Abbott Laboratories Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions A week ago, Abbott Laboratories (NYSE:ABT) came out with a strong set of second-quarter numbers that could potentially…
